Health stocks jump as WHO declares mpox global health emergency

[ad_1] Colorized transmission electron micrograph of monkeypox virus particles (red) found within an infected cell (blue),…

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

[ad_1] Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool…

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

[ad_1] Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked…

CVS slashes profit guidance, will cut $2 billion in expenses as insurance costs climb

[ad_1] The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store…

Novo Nordisk shares dip as Wegovy maker posts earnings miss, cuts operating profit outlook

[ad_1] Novo Nordisk Wegovy manufactured by Novo Nordisk packaging is seen in this illustration photo taken…

Why pharmacy chains like Walgreens and CVS are shuttering locations

[ad_1] In its fiscal third-quarter earnings report to investors in late June, pharmacy chain Walgreens announced…

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study

[ad_1] An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New…

Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction

[ad_1] A test tube is seen in front of displayed Biogen logo in this illustration taken…

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

[ad_1] Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance,…

Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says

[ad_1] The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington,…

Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda

[ad_1] The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb.…

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported second-quarter revenue and adjusted…

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

[ad_1] A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter…

Newseum Global